- BsUFA IV Is Coming: FDA Calls for Public Input November 26, 2025
- HPM Announces the Promotion of Steven Gonzalez to Counsel November 24, 2025
- FDA Issues First Draft Guidance in the Countdown to QMSR November 21, 2025
- HPM to Host Complimentary Webinar on Medical Device Update Year in Review November 19, 2025
- Fabiola Cervantes-Gomez, Ph.D. Joins Hyman, Phelps & McNamara, P.C. as a CMC Regulatory Expert! November 17, 2025
- Big Molecule Watch Blog
- Bloomberg BNA Health Care Blog
- Drug and Device Law Blog
- Eye on FDA
- FDA Matters
- Harvard Law Bill of Health
- IN VIVO Blog
- Internet Drug News.com
- Lachman Consultants Blog
- Medical Devices Today
- Orange Book Blog
- The Orange Book Insights Blog
- Pharma IQ
- Pharmalot
- SCOTUS Blog
- The Volokh Conspiracy
- WLF Legal Pulse
- Advertising and Promotion (Federal Trade Commission)
- Advertising and Promotion (OPDP)
- Animal Drugs and Feeds
- Biosimilars
- Cannabis
- cGMP Compliance
- Consumer Product Safety Commission
- Controlled Substances
- Cosmetics
- COVID19
- Current Affairs
- Dietary Supplements
- Drug Development
- Drug Enforcement Administration
- Enforcement
- FDA News
- Foods
- Foods and Dietary Supplements
- Fraud and Abuse
- Government Pricing
- Hatch-Waxman
- Health Care
- Health Privacy
- Import/Export
- In Vitro Diagnostic Devices
- Jobs
- Medical Devices
- Miscellaneous
- Orphan Drugs
- OTC Drugs and Cosmetics
- Prescription Drugs and Biologics
- Product Jurisdiction and Combination Products
- Reimbursement
- Tissue Products
- Tobacco
- Uncategorized
Access to HPM’s Free FDA Enforcement Webinar Now Available!
May 1, 2025Thanks to everyone who joined us today. We are excited that you were able to join us for our discussion of enforcement under the new FDA. We hope you enjoyed a lively conversation. We appreciated all of the questions we received from the audience. If you were unable to join, you can still watch our recorded webinar here.
Stay tuned for news on future webinars this summer!
Categories: Enforcement
Search FDA Law Blog
Subscribe
Latest Tweets
Tweets by @fdalawblogAwards & Honors
- Best Lawyers in America® – 2025
- Ranked in Chambers USA – 2024
- BsUFA IV Is Coming: FDA Calls for Public Input November 26, 2025
- HPM Announces the Promotion of Steven Gonzalez to Counsel November 24, 2025
- FDA Issues First Draft Guidance in the Countdown to QMSR November 21, 2025
- HPM to Host Complimentary Webinar on Medical Device Update Year in Review November 19, 2025
- Fabiola Cervantes-Gomez, Ph.D. Joins Hyman, Phelps & McNamara, P.C. as a CMC Regulatory Expert! November 17, 2025
- Big Molecule Watch Blog
- Bloomberg BNA Health Care Blog
- Drug and Device Law Blog
- Eye on FDA
- FDA Matters
- Harvard Law Bill of Health
- IN VIVO Blog
- Internet Drug News.com
- Lachman Consultants Blog
- Medical Devices Today
- Orange Book Blog
- The Orange Book Insights Blog
- Pharma IQ
- Pharmalot
- SCOTUS Blog
- The Volokh Conspiracy
- WLF Legal Pulse
- Advertising and Promotion (Federal Trade Commission)
- Advertising and Promotion (OPDP)
- Animal Drugs and Feeds
- Biosimilars
- Cannabis
- cGMP Compliance
- Consumer Product Safety Commission
- Controlled Substances
- Cosmetics
- COVID19
- Current Affairs
- Dietary Supplements
- Drug Development
- Drug Enforcement Administration
- Enforcement
- FDA News
- Foods
- Foods and Dietary Supplements
- Fraud and Abuse
- Government Pricing
- Hatch-Waxman
- Health Care
- Health Privacy
- Import/Export
- In Vitro Diagnostic Devices
- Jobs
- Medical Devices
- Miscellaneous
- Orphan Drugs
- OTC Drugs and Cosmetics
- Prescription Drugs and Biologics
- Product Jurisdiction and Combination Products
- Reimbursement
- Tissue Products
- Tobacco
- Uncategorized